Pages that link to "Q52372585"
Jump to navigation
Jump to search
The following pages link to IRAK1 augments cancer stemness and drug resistance via the AP-1/AKR1B10 signaling cascade in hepatocellular carcinoma. (Q52372585):
Displaying 11 items.
- Sestrin 2 confers primary resistance to sorafenib by simultaneously activating AKT and AMPK in hepatocellular carcinoma (Q57475140) (← links)
- The role of IRAK1 in breast cancer patients treated with neoadjuvant chemotherapy (Q64056246) (← links)
- Metabolic adaptability in metastatic breast cancer by AKR1B10-dependent balancing of glycolysis and fatty acid oxidation. (Q64891091) (← links)
- Diagnostic and Prognostic Potential of AKR1B10 in Human Hepatocellular Carcinoma. (Q64916993) (← links)
- Significant Association Between the MiR146a Genotypes and Susceptibility to Childhood Acute Lymphoblastic Leukemia in Taiwan (Q89930013) (← links)
- LncRNA SNHG7 Functions as an Oncogene in Cervical Cancer by Sponging miR-485-5p to Modulate JUND Expression (Q90247391) (← links)
- Aldo-Keto Reductase Family 1 Member B10 (AKR1B10) overexpression in tumors predicts worse overall survival in hepatocellular carcinoma (Q90618679) (← links)
- Cancer stemness in hepatocellular carcinoma: mechanisms and translational potential (Q90776672) (← links)
- miR-223 overexpression inhibits doxorubicin-induced autophagy by targeting FOXO3a and reverses chemoresistance in hepatocellular carcinoma cells (Q91151354) (← links)
- Inhibitor of Interleukin-1 Receptor-associated Kinases 1/4, Can Increase the Sensitivity of Breast Cancer Cells to Methotrexate (Q96138277) (← links)
- Long Noncoding RNAs Coregulated by Annexin A7 and JNK in Hepatocellular Carcinoma Cells Identified by Whole-Genome Expression Profiling (Q98291755) (← links)